A Phase II, multicenter, randomized, double-blind, placebo-controlled clinical trial of TG-C in Subjects with osteoarthritis (OA) of the hip

At a glance
Trial Overview
Trial Details
Interventions
Trial History
References

X

Trial Profile

A Phase II, multicenter, randomized, double-blind, placebo-controlled clinical trial of TG-C in Subjects with osteoarthritis (OA) of the hip

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 28 Apr 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tonogenchoncel-L (Primary)
Indications Osteoarthritis
Focus Therapeutic Use

Most Recent Events

27 Apr 2023 According to a Kolon TissueGene media release, company announced today that the FDA has allowed the Company to proceed with initiation of a Phase II clinical trial in osteoarthritis (OA) of the hip. Kolon TissueGene has begun activities to initiate the Phase II trial.
10 Dec 2021 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com